The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
126104041 12610404 1 I 20071208 20071219 20160801 20160801 EXP GB-ASTELLAS-2007002500 ASTELLAS 84.63 YR M Y 0.00000 20160801 CN GB GB

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
126104041 12610404 1 PS Erlotinib ERLOTINIB 1 Oral 21743 150 MG TABLET QD
126104041 12610404 2 SS Erlotinib ERLOTINIB 1 Oral UNK UNK, ONCE DAILY 21743 TABLET QD
126104041 12610404 3 SS ERYTHROMYCIN. ERYTHROMYCIN 1 Oral UNK, UNKNOWN FREQ. U 0 FORMULATION UNKNOWN
126104041 12610404 4 C COCODAMOL ACETAMINOPHENCODEINE PHOSPHATE 1 Oral UNK UNK, UNKNOWN FREQ. U 0 FORMULATION UNKNOWN

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
126104041 12610404 1 Non-small cell lung cancer
126104041 12610404 3 Product used for unknown indication
126104041 12610404 4 Product used for unknown indication

Outcome of event

Event ID CASEID OUTC COD
126104041 12610404 OT
126104041 12610404 HO
126104041 12610404 DE

Reactions reported

Event ID CASEID DRUG REC ACT PT
126104041 12610404 Abdominal pain upper
126104041 12610404 Constipation
126104041 12610404 Cough
126104041 12610404 Decreased appetite
126104041 12610404 Diarrhoea
126104041 12610404 Dyspnoea
126104041 12610404 Haemoptysis
126104041 12610404 Lung cancer metastatic
126104041 12610404 Muscle contractions involuntary
126104041 12610404 Nausea
126104041 12610404 Urinary incontinence
126104041 12610404 Vomiting

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
126104041 12610404 1 20071130 0
126104041 12610404 2 20080103 20080131 0
126104041 12610404 3 20071208 20071209 0
126104041 12610404 4 20071208 20080118 0